TRXC - TransEnterix, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
18,766
24,102
7,111
1,519
0
Cost of Revenue
16,287
16,171
6,727
1,069
0
Gross Profit
2,479
7,931
384
450
0
Operating Expenses
Research Development
23,227
21,823
21,989
29,273
29,669
Selling General and Administrative
45,862
39,590
29,811
19,964
10,686
Total Operating Expenses
79,583
72,281
59,658
56,204
42,540
Operating Income or Loss
-77,104
-64,350
-59,274
-55,754
-42,540
Interest Expense
3,673
4,208
-
-
-
Total Other Income/Expenses Net
7,045
2,004
-86,060
-67,860
-3,831
Income Before Tax
-72,426
-65,154
-148,096
-125,503
-47,972
Income Tax Expense
-3,083
-3,377
-3,300
-5,523
-1,024
Income from Continuing Operations
-69,343
-61,777
-144,796
-119,980
-46,948
Net Income
-69,343
-61,777
-144,796
-119,980
-46,948
Net Income available to common shareholders
-69,343
-61,777
-144,796
-119,980
-46,948
Reported EPS
Basic
-
-0.30
-0.97
-1.07
-0.59
Diluted
-
-0.30
-0.97
-1.07
-0.59
Weighted average shares outstanding
Basic
-
207,199
148,744
112,185
79,628
Diluted
-
207,199
148,744
112,185
79,628
EBITDA
-
-47,658
-48,930
-46,845
-39,107